ChemPartner
Newly-launched database offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs
SHANGHAI, CHINA / ACCESSWIRE / December 22, 2023 / ChemPartner, a global leader in drug discovery and development services, today announced the launch of its long-awaited Biology Database. This innovative platform serves as a centralized hub, empowering ChemPartner's clientele with seamless access to a wealth of information on the organization's cutting-edge preclinical platforms. The database includes 800+ tumor models, 30+ cancer types, 20,000 genes, 2,300+ pathways, 1,800 SoC data from literature (500 internal), and 30+ analytic modules.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Screenshot of the online Biology Database from ChemPartner
ChemPartner's renowned biology and pharmacology department, known for its vanguard oncology, immunology, CNS, and metabolic services, has curated an extensive collection of in vitro and in vivo models. The database boasts over 2,000 biochemistry assays, 800 cell lines, 500 patient-derived xenograft (PDX) models, 350 cell-derived xenograft (CDX) models, and 50 syngeneic models. Each model is meticulously characterized with comprehensive data encompassing genomics, pharmacology, histopathology, and relevant clinical information.
Cell Line Models - ChemPartner Biology Database
To ensure a smooth and efficient rollout of this substantial volume of data, the database will be introduced in stages. We are delighted to announce that the first stage, featuring cell line data, is now live on https://database.chempartner.com. Subsequent stages will include CDX, syngeneic, and PDX models, followed by biochemistry data.
The Biology Database, a flagship online collaborative platform, prominently features the Tumor Model Database. This revolutionary resource offers an array of features, including:
- Unified Data Hub: Integration of dispersed tumor model data into a centralized database for efficient management and retrieval, simplifying user access to diverse tumor models.
- Detailed Annotations: Each model is accompanied by intricate annotations including genomics, pathology, and pharmacology data, enabling rapid understanding of model characteristics and suitability for specific research needs.
- Rapid Search and Filtering: Multidimensional search and filtering capabilities empower researchers to swiftly locate models based on cancer type, genomic features, drug sensitivity, and more.
- Data Analysis and Mining: Robust tools facilitate tasks like drug mechanism analysis and biomarker discovery through differential gene expression and drug sensitivity analyses, supporting informed research decisions.
- Data Visualization: Intuitive charts, statistics, and visualization tools present complex data clearly and concisely, aiding in model selection and analysis.
Dr. Lilly Xu, President of Shanghai ChemPartner, expressed enthusiasm about the launch saying, "We are excited to provide our customers with access to this powerful new resource. This comprehensive database will make it easier for our customers to find and use the right models for their research, propelling drug development towards new heights with better precision, efficacy, and efficiency."
-
About ChemPartner
ChemPartner is a leading global CRO and CDMO providing drug discovery, development, and manufacturing services to the pharmaceutical and biotechnology industries. With a team of over 2,000 scientists across multiple countries, ChemPartner offers a comprehensive range of services including preclinical pharmacology, toxicology, drug metabolism and pharmacokinetics, chemistry development, and biologics development. For more information, please visit https://chempartner.com and connect with ChemPartner on LinkedIn, X, and YouTube.
Contact Information
Sarah Stapleton
Marketing Director
news@chempartner.com
6504199974
Related Images
|
SOURCE: ChemPartner
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Air T, Inc. Announces Closing of Regional Express Acquisition18.12.2025 23:10:00 CET | Press release
MINNEAPOLIS, MN / ACCESS Newswire / December 18, 2025 / Air T, Inc. (NASDAQ:AIRT) is pleased to announce the successful closing of its acquisition of Regional Express Holdings Limited (Rex), Australia's leading regional airline. Air T now owns 100% of Rex and looks forward to beginning a new chapter for Rex and the regional communities it serves across Australia. The transaction includes a comprehensive financing structure designed to support Rex's operations and future growth: Air T is providing a $50 million AUD credit facility that is funded by one of our investor partners. We anticipate that Rex will use this facility to bring its fleet fully back into service, from approximately 31 flyers currently to 45 flyers within the next two years. The Commonwealth of Australia will continue to be a secured creditor of Rex. Rex will have access to an additional undrawn $60 million AUD loan from the Commonwealth of Australia to support the overhaul of its current fleet of Saab 340s and genera
Ascension Advisory Completes Industrial Sale Leaseback in Toledo, Spain on Behalf of OpenGate Capital17.12.2025 23:05:00 CET | Press release
TOLEDO, SPAIN / ACCESS Newswire / December 17, 2025 / Ascension Advisory is pleased to announce the successful closing of an industrial sale leaseback transaction in Toledo, Spain, completed on behalf of Aluminium Solutions Group (ASG), a portfolio company of OpenGate Capital. Aluminium Solutions Group is an industrial manufacturing business specializing in aluminium extrusion and value-added aluminium solutions, serving a range of industrial and commercial end markets across Europe. OpenGate Capital is a global private equity firm specializing in the acquisition and operation of businesses to create new value through operational improvements, innovation and growth. The transaction involved a 44,026 square meter industrial facility situated on a 56,330 square meter site, representing a mission-critical manufacturing asset for ASG's operations in Spain, Extrusiones de Toledo ("EXTOL"). As part of the sale leaseback, EXTOL executed a new long-term triple-net lease, allowing the company t
TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care17.12.2025 18:45:00 CET | Press release
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / December 17, 2025 / TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, and the National Association of Pediatric Nurse Practitioners (NAPNAP), The Leader in Pediatric Education for Nurse Practitioners®, have announced they will jointly develop a global micro-credential to help advance the knowledge and skills of the world's pediatric nursing workforce. The collaboration aims to improve health outcomes for infants, children, adolescents, and young adults worldwide amid a global shortage of pediatric nurses that is limiting access to evidence-based pediatric care in countries of all income levels. The partners envision that their micro-credential program will be the centerpiece of a larger initiative to engage global stakeholders in educating, assessing, and credentialing the nursing workforce in this specialization. A micro-credential is a short, competency-based recognition for specific s
SK tes Achieves NCSC CAS-S Accreditation for Comprehensive Onsite and Offsite Data Destruction and Sanitisation Services Across the UK17.12.2025 15:00:00 CET | Press release
LONDON, UK / ACCESS Newswire / December 17, 2025 / SK tes, a global leader in secure technology lifecycle management, is proud to announce that both its UK sites - Cannock, West Midlands and Irvine, Scotland - have achieved accreditation to the Sanitisation Assurance (CAS-S) Scheme by the UK's National Cyber Security Centre (NCSC) for its secure on-site shredding service. This dual-site accreditation enables SK tes to deliver secure data destruction and sanitisation services nationwide from these two strategic locations, to support clients across the whole of the UK. The CAS-S scheme certifies commercial IT asset sanitisation providers to rigorous government standards, ensuring central government (HMG) customers can easily access services that fully comply with NCSC requirements. With this accreditation, SK tes is authorised to provide: Mobile (offsite) destruction services up to SECRET: Devices are destroyed at the client's premises, ensuring sensitive information never leaves the org
AWM Wraps Up 2025 with Multiple Surf Venue Grand Openings16.12.2025 16:05:00 CET | Press release
Ending the Year on a High Note SOLANA BEACH, CA / ACCESS Newswire / December 16, 2025 / American Wave Machines, the surf technology company behind PerfectSwell® Surf Venues worldwide, concludes banner year with two grand openings and expansion into new markets. São Paulo Surf Club Key Year End Highlights: Riyue Bay: November 11 China Tourism Group celebrated the grand opening of PerfectSwell® Riyue Bay Surf Resort Zion: November 20 The Foundation Ceremony of PerfectSwell® Zion took place in Utah. São Paulo: November 29 JHSF celebrated the grand opening of São Paulo Surf Club "This year's results reflect a herculean effort from the team on improving efficiency, product delivery and commissioning. Finishing with two grand openings in one month is perhaps our most notable achievement. With PerfectSwell® Zion well underway and a third pool starting up in Brazil, 2026 will be just as memorable." - CEO Bruce McFarland "The wave quality achievements made this year have exceeded the expectatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom